AUPH
Aurinia Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.95
-0.42 ▼ -2.92%
🌙 3월 13일 5:08 PM ET (한국 3/14 06:08)
$14.19
+0.24 ▲ +1.72%
| Index | RUT | P/E | 6.72 | EPS (ttm) | 2.08 | Insider Own | 11.75% | Shs Outstand | 0.13B | Perf Week | -2.58% |
| Market Cap | 1.85B | Forward P/E | 13.18 | EPS next Y | 30.12% | Insider Trans | 6.11% | Shs Float | 0.12B | Perf Month | -3.86% |
| Enterprise Value | 1.53B | PEG | - | EPS next Q | 0.2 | Inst Own | 57.71% | Short Float | 8.31% | Perf Quarter | -9.83% |
| Income | 0.29B | P/S | 6.55 | EPS this Y | -60.71% | Inst Trans | - | Short Ratio | 9.81 | Perf Half Y | 9.15% |
| Sales | 0.28B | P/B | 3.18 | EPS next 5Y | -15.03% | ROA | 43.47% | Short Interest | 9.75M | Perf YTD | -12.54% |
| Book/sh | 4.39 | P/C | 4.66 | EPS past 3/5Y | - | ROE | 59.91% | 52W High | -15.66% ($16.54) | Perf Year | 72.01% |
| Cash/sh | 2.99 | P/FCF | 13.67 | Sales past 3/5Y | 28.3% 41.38% | ROIC | 44.98% | 52W Low | 104.4% ($6.82) | Perf 3Y | 56.74% |
| Dividend Est. | - | EV/EBITDA | 11.3 | EPS Y/Y TTM | 5205.15% | Gross Margin | 88.46% | Volatility(W/M) | 3.27% 3.67% | Perf 5Y | 1.38% |
| Dividend TTM | - | EV/Sales | 5.41 | Sales Y/Y TTM | 20.38% | Oper. Margin | 41.01% | ATR (14) | 0.55 | Perf 10Y | 430.42% |
| Dividend Ex-Date | - | Quick Ratio | 4.76 | EPS Q/Q | 15628.87% | Profit Margin | 101.47% | RSI (14) | 41.48 | Recom | 1.86 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.25 | Sales Q/Q | 28.81% | SMA20 | -3.26% ($14.42) | Beta | 1.57 | Target Price | $17 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2000000 | SMA50 | -5.2% ($14.72) | Rel Volume | 1.01 | Prev Close | $14.37 |
| Employees | 128 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 606.05% 3.24% | SMA200 | 11.05% ($12.56) | Avg Volume(3M) | 0.99M | Price | $13.95 |
| IPO | 2003/10/20 | Option/Short | Yes/Yes | Trades | 10669 | Volume | 1,003,420 | Change | -2.92% |
뉴스 로딩 중...